Sponsored Content

Exhibition Recap | Hygieia Biotech Highlights Longevity Actives & Biomanufacturing at SupplySide Global (SSG) 2026

Hygieia Biotech wrapped up a successful presentation at SupplySide Global (SSG) 2026 in Las Vegas. Showcasing proprietary enzymatic biosynthesis via the Zymevolver® platform alongside human clinically backed EnerLive® Ca-AKG and longevity ingredients, Hygieia demonstrated its full-spectrum R&D and ODM manufacturing capabilities to global nutraceutical partners.

From October 28 to 30, 2026, SupplySide Global (SSG) — a flagship global gathering for nutritional health and innovative ingredients — concluded at Mandalay Bay in Las Vegas, USA. Hygieia Biotech (https://www.hygieiabiotech.com) presented its innovative raw materials, proprietary technology platform Zymevolver®, scientific research findings, and functional nutrition product solutions, showcasing its R&D expertise and scaled manufacturing capabilities to global industry partners.

The global functional nutrition industry is undergoing three key transitions: from conventional raw material supply to technology-led innovation, from single-ingredient applications to integrated product solutions, and from experience-led development to evidence-backed validation supported by randomized controlled trial (RCT) data. Market competition now extends beyond finished products to the full scope of ingredient R&D, advanced formulation, scientific verification, and industrial-scale production.

Source Innovation: Upstream Biotechnology PlatformsIngredient innovation is a critical foundation for differentiated health supplements. Hygieia extends its R&D capacity to the upstream source of active ingredient synthesis. Backed by approximately 1,500 ㎡ of specialized biotechnology laboratories, the company has established comprehensive platforms for strain engineering, enzyme evolution, and biocatalytic process development:- Zymevolver® Enzyme Evolution Platform: Through high-throughput screening and targeted enzyme design, Hygieia drives pure, green biocatalysis without harsh chemical residues.- Advanced Formulation Delivery: Covering microencapsulation (DelMiCap™), bioavailability optimization, and ＜500 nm ultra-fine nanosuspension technologies to resolve water-solubility and stability bottlenecks in liquid and solid formats.

Featured Active Ingredients on DisplayDuring the event, formulators and sourcing managers explored Hygieia’s core longevity and metabolic portfolio:1. EnerLive® Ca-AKG (Calcium Alpha-Ketoglutarate): High-purity metabolic intermediate supported by human clinical studies, enzyme-engineered crystal stability, and global quality certifications (ISO9001, FSSC 22000, HACCP, Halal, Kosher).2. SirtuAct® β-NMN (Nicotinamide Mononucleotide): HPLC Purity ≥99.5%, optimized bulk density tailored for premium solid and liposomal formulas.3. Nicotinamide Riboside (NRHM & NR-Cl): Available in both high-solubility hydrogen malate and standard chloride forms.4. Spermidine Trihydrochloride: High-potency active ingredient with complete analytical traceability.

End-to-End Industrial TranslationBacked by an approximately 8,000 ㎡ GMP-compliant manufacturing base, Hygieia bridges laboratory discoveries with commercial-scale production. Integrating formulation design, regulatory compliance support, and comprehensive ODM/CDMO manufacturing services, the company helps global brand partners shorten product development timelines and achieve distinct market advantages.

For in-depth event insights, formulation consultation, or to request technical dossiers (COA/TDS) and complimentary sample kits, read our full recap at: https://www.hygieiabiotech.com/hygieia-supplyside-global-2026/

Read More